Skip to content

Liver Cancer Clinical Trials

Hepatobiliary Cancer

Learn More About Liver Cancer

For general information on liver cancer (including risk factors, symptoms, diagnosis, and treatment) visit the Cancer Council’s website:

Read More

General Enquiries

For general questions about trial availability, eligibility, or the referral process, please contact us using the form below. Our team will respond as soon as possible.

Enquiry Form
Protocol NumberCancer TypeStudy NameInterventionMechanism of ActionRecruitment StatusSponsorClinical.Trials.gov IDClick to Enquire
GRWD5769-ST-01Hepatobiliary CancerA Modular, Multi-part, Multi-arm, Open-label, Phase I/II Study to Evaluate the Safety and Tolerability of GRWD5769 Alone and in Combination With Anticancer Treatments in Patients With Solid MalignanciesImmunotherapyNovel EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial – 1).Open - RecruitingGrey Wolf Therapeutics Pty LtdNCT06923761Enquire Now
SR-8541A-001Hepatobiliary CancerPhase 1, Dose Escalation, Safety, Tolerability, and Pharmacokinetic Study of SR-8541A (ENPP1 Inhibitor) Administered Orally as Monotherapy or in Combination With Checkpoint Inhibitors in Subjects With Advanced/Metastatic Solid TumorsTargetedENPP1 inhibitorOpen - RecruitingStingray TherapeuticsNCT06063681Enquire Now
SSGJ-709-101Hepatobiliary CancerA Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Anti-tumor Activity of SSGJ-709 in Patients With Advanced Malignant TumorsImmunotherapyAnti-PD-1 and anti-LAG-3 bispecific antibodyOpen - RecruitingShenyang Sunshine Pharmaceutical Co., LTD.NCT07016490Enquire Now
CP-IVX001Hepatobiliary CancerA Phase 1 open-label, non-randomized, multi-center clinical trial of intratumoral IVX037 as monotherapy and in combination with an immune checkpoint inhibitor in patients with advanced micro satellite-stable (MSS) colorectal cancer, or gastric or ovarian cancer.ImmunotherapyLive EchoVirus Open - RecruitingImmVirx Pty LtdNCT05427487Enquire Now
For general enquiries, please contact us here.